Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into IsoRay, Inc. (MYSE MKT: ISR).
On May 21, 2015, TheStreet.com published an article claiming that some of IsoRay’s promotional press releases “take liberties with clinical data using clever, selective editing.” In particular, the article stated that the Company’s recent press releases regarding the publication of a study concerning its Celsium-131 product was misleading.
On this news, the price of MDC’s shares plummeted by over 35%.
KSF’s investigation is focusing on whether IsoRay and/or its officers and directors violated state or federal securities laws.
If you are as IsoRay shareholder who has suffered losses related to your investment or have information that would assist KSF in its investigation, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com).
About Kahn Swick & Foti, LLC
KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities class action and shareholder derivative litigation with offices in New York, California and Louisiana. KSF's lawyers have significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders.
To learn more about KSF, you may visit www.ksfcounsel.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150521006605/en/
Contacts:
Lewis Kahn, 1-877-515-1850
Managing
Partner
lewis.kahn@ksfcounsel.com
